Reckitt Benckiser Group (LON:RB) had its target price boosted by UBS Group from GBX 6,000 ($78.40) to GBX 6,400 ($83.63) in a research report sent to investors on Monday, September 17th, www.boersen-zeitung.de reports. The brokerage currently has a neutral rating on the stock.
Other analysts also recently issued reports about the stock. JPMorgan Chase & Co. set a GBX 7,000 ($91.47) target price on shares of Reckitt Benckiser Group and gave the stock a buy rating in a research report on Monday, July 23rd. Cfra set a GBX 7,500 ($98.00) target price on shares of Reckitt Benckiser Group and gave the stock a buy rating in a research report on Monday, July 30th. Jefferies Financial Group set a GBX 6,800 ($88.85) price objective on shares of Reckitt Benckiser Group and gave the company a neutral rating in a research report on Wednesday, August 1st. Shore Capital reissued a hold rating on shares of Reckitt Benckiser Group in a research report on Friday, July 27th. Finally, Kepler Capital Markets set a GBX 6,300 ($82.32) price objective on shares of Reckitt Benckiser Group and gave the company a neutral rating in a research report on Friday, July 27th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and ten have assigned a buy rating to the company’s stock. Reckitt Benckiser Group has an average rating of Hold and a consensus target price of GBX 7,115.48 ($92.98).
Shares of LON:RB traded down GBX 142 ($1.86) during midday trading on Monday, reaching GBX 6,449 ($84.27). The company’s stock had a trading volume of 1,451,207 shares, compared to its average volume of 1,720,000. Reckitt Benckiser Group has a 12-month low of GBX 5,562 ($72.68) and a 12-month high of GBX 8,110.43 ($105.98).
The firm also recently disclosed a dividend, which was paid on Thursday, September 27th. Stockholders of record on Thursday, August 16th were paid a GBX 70.50 ($0.92) dividend. This represents a dividend yield of 1.04%. The ex-dividend date of this dividend was Thursday, August 16th.
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers products for the treatment of analgesic and gastro-intestinal problems, sore throat, cough, pain, and flu, as well as wellness products in sexual wellbeing, footcare, vitamins, and supplements under the Durex, Gaviscon, Nurofen, Mucinex, Scholl/Amopé, and Strepsils brand names.
Featured Story: What is a conference call?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.